WEREWOLF THERAPEUTICS, INC. Capital Expenditures
WEREWOLF THERAPEUTICS, INC. (HOWL) reported Capital Expenditures of $0 for the 12-month period ending 2025-12-31, per its S-4 filed 2026-09-22.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-09-22
- WEREWOLF THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- WEREWOLF THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- WEREWOLF THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- WEREWOLF THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- WEREWOLF THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $769.00K, a 78.70% decline from fiscal 2022.
- WEREWOLF THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $3.61M, a 625.10% increase from fiscal 2021.
- WEREWOLF THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2021 was $498.00K, a 11.07% decline from fiscal 2020.
- WEREWOLF THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2020 was $560.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: S-4 12 month − 10-Q 9 month · filed 2026-09-22 | $0.00 derived: sum of 2 quarters · filed 2026-09-22 | $0.00 derived: sum of 3 quarters · filed 2026-09-22 | $0.00 S-4 · filed 2026-09-22 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $0.00 10-Q · filed 2025-11-04 | $123.00K derived: sum of 4 quarters · filed 2026-09-22 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $123.00K derived: sum of 3 quarters · filed 2026-09-22 | $126.00K derived: sum of 4 quarters · filed 2026-09-22 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $123.00K derived: sum of 2 quarters · filed 2026-09-22 | $126.00K derived: sum of 3 quarters · filed 2026-09-22 | $143.00K derived: sum of 4 quarters · filed 2026-09-22 |
| 2024-12-31 | $123.00K derived: S-4 12 month − 10-Q 9 month · filed 2026-09-22 | $126.00K derived: sum of 2 quarters · filed 2026-09-22 | $143.00K derived: sum of 3 quarters · filed 2026-09-22 | $254.00K S-4 · filed 2026-09-22 |
| 2024-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $20.00K derived: sum of 2 quarters · filed 2025-11-04 | $131.00K 10-Q · filed 2025-11-04 | $329.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $128.00K 10-Q · filed 2025-08-14 | $326.00K derived: sum of 3 quarters · filed 2025-08-14 | $547.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $111.00K 10-Q · filed 2025-05-08 | $309.00K derived: sum of 2 quarters · filed 2025-05-08 | $530.00K derived: sum of 3 quarters · filed 2025-05-08 | $712.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $198.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $419.00K derived: sum of 2 quarters · filed 2025-03-11 | $601.00K derived: sum of 3 quarters · filed 2025-03-11 | $769.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $221.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $403.00K derived: sum of 2 quarters · filed 2024-11-07 | $571.00K 10-Q · filed 2024-11-07 | $1.09M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $182.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $350.00K 10-Q · filed 2024-08-08 | $868.00K derived: sum of 3 quarters · filed 2024-08-08 | $2.82M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $168.00K 10-Q · filed 2024-05-03 | $686.00K derived: sum of 2 quarters · filed 2024-05-03 | $2.64M derived: sum of 3 quarters · filed 2024-05-03 | $3.75M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $518.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $2.47M derived: sum of 2 quarters · filed 2024-03-07 | $3.58M derived: sum of 3 quarters · filed 2024-03-07 | $3.61M 10-K · filed 2024-03-07 |
| 2022-09-30 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $3.06M derived: sum of 2 quarters · filed 2023-11-14 | $3.09M 10-Q · filed 2023-11-14 | $3.37M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.14M 10-Q · filed 2023-08-10 | $1.41M derived: sum of 3 quarters · filed 2023-08-10 | $1.51M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $28.00K 10-Q · filed 2023-05-11 | $300.00K derived: sum of 2 quarters · filed 2023-05-11 | $402.00K derived: sum of 3 quarters · filed 2023-05-11 | $513.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $374.00K derived: sum of 2 quarters · filed 2023-03-23 | $485.00K derived: sum of 3 quarters · filed 2023-03-23 | $498.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $102.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $213.00K derived: sum of 2 quarters · filed 2022-11-10 | $226.00K 10-Q · filed 2022-11-10 | $235.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $111.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $124.00K 10-Q · filed 2022-08-11 | $133.00K derived: sum of 3 quarters · filed 2022-08-11 | $190.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $13.00K 10-Q · filed 2022-05-10 | $22.00K derived: sum of 2 quarters · filed 2022-05-10 | $79.00K derived: sum of 3 quarters · filed 2022-05-10 | $124.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $66.00K derived: sum of 2 quarters · filed 2022-03-24 | $111.00K derived: sum of 3 quarters · filed 2022-03-24 | $560.00K 10-K · filed 2022-03-24 |
| 2020-09-30 | $57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $102.00K derived: sum of 2 quarters · filed 2021-11-10 | $551.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $494.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $449.00K 10-Q · filed 2021-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |